Navigation Links
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Date:3/13/2009

ter Capital Management, LLC and associated companies decreased holdings in the Company to 2,814,932 common shares, representing 4.8 per cent voting rights attached to the issued common share capital of the Company, being 58,216,309 common shares. This information is being provided in order to comply with the rules for AIM listed companies.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development. The Company is currently developing two late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM), and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is significantly differentiated from all other currently marketed EGFR-targeting agents due to its remarkably benign side-effect profile. Nimotuzumab's anti-tumor activity has led to its approval for marketing in over 12 countries, In more than 3,500 patients reported as having been treated with nimotuzumab worldwide to date, no Grade IV incidents of radiation dermatitis have been described, severe rash has not been observed and reports of the other severe side-effects that are typical of EGFR-targeting molecules have been rare. Nimotuzumab is licensed to YM's majority-owned subsidiary, CIMYM BioSciences Inc., by CIMAB S.A., and was developed at the Center of Molecular Immunology. YM is developing AeroLEF for the treatment of moderate to severe acute pain. The product is differentiated from o
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
2. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
3. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
4. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
5. YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia
6. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
7. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
10. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
11. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... novel therapies for cancer, today announced results for its ... - http://photos.prnewswire.com/prnh/20140805/133834 "Despite a ... pleased with how the Company is positioned entering fiscal ... President and Chief Executive Officer of MEI Pharma. "While ...
(Date:9/2/2015)... PARK, Calif. , Sept. 2, 2015 BioPharmX ... today announced that Jim Pekarsky , chief executive officer ... Renshaw 17th Annual Global Investment Conference taking place, September 8-10, ... . Mr. Pekarsky is scheduled to present ... Astor Suite A (2 nd floor). A ...
(Date:9/2/2015)... -- Tumultuous market conditions – including changes in medical ... – have led more than half of today,s physicians ... This marks the first time that the number of ... according to the spring 2015 AccessMonitor™ report ... AccessMonitor™ aggregates sales-call records from ...
Breaking Medicine Technology:MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5
... Pa., March 21, 2012 The Huntzinger Management ... and managed services consulting, today further illustrated its commitment ... healthcare community that has yet to prepare for ICD-10. ... Chapman, adding more than 25 years of provider operations ...
... 21, 2012   iBio, Inc. (NYSE AMEX: ... human trial of iBioLaunch-produced H1N1 influenza vaccine (HAC1) that ... dose-escalation study was conducted to assess the safety and ... collaborator, the Fraunhofer USA Center for Molecular Biotechnology. The ...
Cached Medicine Technology:Huntzinger Management Group, Inc., (HMG) Further Invests in Healthcare Industry's "90 Percent" 2iBio Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial 2iBio Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... , ... September 01, 2015 , ... For many men, the first thing they notice ... were often forced to wear a looser fitting shirt with a collar that doesn’t close ... a finger between their collar and skin all day because it’s uncomfortable. Now men ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... 2015 , ... The Journal of Pain Research has published the ... , As corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic ... to better understand how migraine headaches impact the lives of migraineurs. We asked migraineurs ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... According ... Medical Association, individuals with type 2 diabetes that participated in a three year study ... three years down the line if they elected weight loss surgery at the onset ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... 19 Delta Dental of Illinois has ... of Illinois at Chicago,College of Dentistry to ... renovations are complete, the clinic will be ... Dentistry Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... Ind., Dec. 19 Zimmer Holdings, Inc.,(NYSE: ZMH ... announced,today it will be participating in the 26th Annual ... at 12:00 p.m. Eastern Time., A live webcast ... website at http://investor.zimmer.com . The webcast will,be archived ...
... takes the first step in offering nationwide services, ... announced its plan to expand its services to four ... Area during,the summer of 2007, and is now expanding ... The company hosts a website where healthcare,providers and patients ...
... (MGH) researchers have identified a new molecular pathway that ... This early-stage kidney disease affects 100 million people around ... the kidneys filtering structures. Blocking this pathway could ... slow the process of kidney failure. The research ...
... Device might aid in the detection and monitoring of cancer, ... U.S. team has developed a microchip device that can detect ... has a silicon chip with about 80,000 microscopic posts. Each ... expressed by most solid tumors. The device is able to ...
... Massachusetts General Hospital (MGH) Biomicroelectromechanical Systems (BioMEMS) Resource Center ... device that can isolate, enumerate and analyze circulating tumor ... viable cells from solid tumors carried in the bloodstream ... Because of their rarity and fragility, it has ...
Cached Medicine News:Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Microchip Spots Stray Tumor Cells in the Bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 3
... test setup, try Cadwell paired disc electrodes. ... The custom-molded contacts are 10 mm (0.4 ... solid stainless steel with a locator pin ... color coded and available in twisted pairs. ...
... Video Camera System (NTSC)With Maxenon PowerPlus ... surgeon's eye view of any procedure. ... or digital files for later use. ... 8" to 36". Automatic Iris and ...
... chloride ring electrodes fit pediatric ... with minicrocodile clip lead wires ... (4 in) long, 0.6 cm ... package contains 50 individually sealed ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Medicine Products: